avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hbp1
|
ENSMUSG00000002996.11 | high mobility group box transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hbp1 | mm10_v2_chr12_-_31950535_31950560 | 0.21 | 2.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
3.0 | 9.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
2.2 | 8.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.2 | 6.5 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
2.1 | 21.4 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
2.0 | 7.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.8 | 5.5 | GO:0048007 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.6 | 4.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
1.4 | 4.1 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
1.3 | 3.9 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) |
1.3 | 7.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.2 | 16.3 | GO:0015747 | urate transport(GO:0015747) |
1.1 | 3.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.1 | 35.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.0 | 2.9 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.9 | 2.8 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.9 | 2.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.9 | 2.7 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.9 | 4.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.9 | 13.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 2.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 3.8 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.7 | 2.0 | GO:0019448 | cysteine catabolic process(GO:0009093) glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-cysteine catabolic process(GO:0019448) L-alanine catabolic process(GO:0042853) L-cysteine metabolic process(GO:0046439) |
0.6 | 1.9 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 1.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.6 | 2.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 2.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 4.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 1.8 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
0.6 | 2.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 1.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.5 | 5.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 5.5 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.5 | 3.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 5.3 | GO:0070189 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.5 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 3.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 1.6 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.4 | 1.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.4 | 3.9 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 1.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 1.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 1.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 2.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 1.1 | GO:1990705 | intrahepatic bile duct development(GO:0035622) cholangiocyte proliferation(GO:1990705) |
0.4 | 4.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 1.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 2.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 2.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 3.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.3 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 2.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 1.2 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 7.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.3 | 4.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.3 | 2.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 3.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 3.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 1.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.1 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.3 | 1.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 1.0 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.3 | 3.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 1.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.2 | GO:0060295 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 1.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 1.9 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.2 | 1.6 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.2 | 0.7 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 0.7 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 0.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.2 | 0.4 | GO:0002362 | CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment(GO:0002362) |
0.2 | 1.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.7 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 1.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 1.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 1.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.6 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 1.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 0.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 2.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 3.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 1.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.7 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.2 | 1.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 10.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.2 | 5.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 3.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 0.5 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.2 | 0.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 0.8 | GO:0009446 | spermidine biosynthetic process(GO:0008295) putrescine biosynthetic process(GO:0009446) |
0.2 | 0.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.4 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.9 | GO:0042997 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.9 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.6 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.7 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.4 | GO:1990869 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) negative regulation of lymphangiogenesis(GO:1901491) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.1 | 0.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 1.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 2.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 4.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.5 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 1.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 1.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 1.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 1.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 2.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 3.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 2.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 1.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.5 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.3 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 0.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 2.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.3 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 0.3 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 1.0 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.1 | GO:0021508 | floor plate formation(GO:0021508) |
0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 2.2 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 1.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 1.7 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 7.9 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 1.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.8 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.7 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.3 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 0.8 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.2 | GO:0042697 | menstrual cycle phase(GO:0022601) menopause(GO:0042697) |
0.1 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 5.4 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.5 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 3.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 1.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.8 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.9 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 1.9 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.3 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 1.9 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 2.8 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 1.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 1.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 1.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 1.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.2 | GO:1902856 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 1.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.7 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 1.0 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.8 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 2.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of tooth mineralization(GO:0070172) regulation of enamel mineralization(GO:0070173) |
0.0 | 0.9 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.0 | 0.1 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 1.4 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.3 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.6 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 1.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.3 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 1.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 1.2 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 1.2 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.0 | 0.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 3.3 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 3.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 1.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.9 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.2 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 3.3 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.7 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.5 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.5 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.9 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.0 | 0.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.4 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 1.7 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 2.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.6 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.4 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.2 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 2.0 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.3 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.7 | 5.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 6.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 2.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 1.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 4.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 1.1 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 1.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 4.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.4 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.7 | GO:0036019 | endolysosome(GO:0036019) |
0.2 | 3.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.7 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.2 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 3.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 1.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 21.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 6.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.1 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 2.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 4.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.1 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 2.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 3.2 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 2.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 13.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 1.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 3.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 2.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 94.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.3 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 2.7 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 1.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 8.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 3.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 2.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 3.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 7.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 6.7 | GO:0014069 | postsynaptic density(GO:0014069) |
0.0 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.4 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 1.3 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 1.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.6 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
2.8 | 14.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.5 | 10.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.5 | 4.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
2.4 | 9.4 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
2.2 | 8.9 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
2.2 | 6.5 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
1.7 | 6.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.7 | 5.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.6 | 60.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.5 | 9.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.5 | 4.4 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
1.3 | 4.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.3 | 9.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.2 | 17.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.1 | 6.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.1 | 5.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 23.8 | GO:0070330 | aromatase activity(GO:0070330) |
0.8 | 4.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.8 | 2.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.8 | 15.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.7 | 5.1 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 5.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 4.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.7 | 2.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 1.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.6 | 4.3 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.6 | 1.8 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.6 | 2.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.6 | 1.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 3.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 2.0 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 1.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 1.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 3.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 3.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.5 | 6.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 1.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.4 | 3.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 1.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.4 | 1.6 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.4 | 1.2 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.4 | 10.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 7.7 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 4.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.4 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 1.1 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 2.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 2.7 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.3 | 1.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.2 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.3 | 1.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 1.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.7 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 2.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.6 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.2 | 1.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.2 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 4.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 2.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.8 | GO:0008384 | NF-kappaB-inducing kinase activity(GO:0004704) IkappaB kinase activity(GO:0008384) |
0.2 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 0.8 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 2.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 2.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 3.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 2.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.6 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 1.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 3.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 2.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 2.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 1.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 1.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 12.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 2.4 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.1 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 3.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 7.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 1.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 2.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 3.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0019809 | spermidine binding(GO:0019809) |
0.1 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0003681 | bent DNA binding(GO:0003681) |
0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.2 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.1 | 2.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.2 | GO:0051381 | histamine binding(GO:0051381) |
0.1 | 0.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 2.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 2.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 1.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 7.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 1.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 1.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 2.8 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 3.6 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 2.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 2.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.0 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 4.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.0 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 1.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 1.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 3.0 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 1.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 1.1 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 2.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 2.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 4.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.2 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 1.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 5.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 4.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 4.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 3.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 2.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 2.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 3.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 2.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 4.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 14.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.8 | 6.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 2.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 13.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 5.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 4.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 22.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 4.8 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.3 | 5.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 3.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 3.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 6.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 3.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 16.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 3.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 5.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 3.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 4.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |